Substituted quinazoline derivatives as inhibitors of aurora kinases
US7402585B2 · kind B2 · utility
9Cited by
3References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2002 |
| Grant date | Jul 22, 2008 |
| Priority date | — |
| Expiry date | Feb 26, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides quinazoline derivatives of formula (I): in the preparation of a medicament for use in the inhibition of Aurora kinase and also novel quinazoline derivatives, processes for their preparation, pharamceutical compositions containing them and their use in therapy
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.